Arbutus Biopharma Aktie
WKN DE: A14XMD / ISIN: CA03879J1003
06.08.2025 13:49:24
|
Arbutus Biopharma Corp. Q2 Earnings Summary
(RTTNews) - Below are the earnings highlights for Arbutus Biopharma Corp. (ABUS):
Earnings: $2.523 million in Q2 vs. -$19.796 million in the same period last year. EPS: $0.01 in Q2 vs. -$0.11 in the same period last year. Revenue: $10.739 million in Q2 vs. $1.726 million in the same period last year.
ABUS was up by 3.81% at $3.540 in the pre-market trade on the Nasdaq.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Arbutus Biopharma Corpmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Arbutus Biopharma Corpmehr Analysen
Aktien in diesem Artikel
Arbutus Biopharma Corp | 3,66 | -0,22% |
|